Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Carmichael

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|October 9, 2003
Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginineNathan W Luedtke, Peter Carmichael, Yitzhak Tor
ACS Nano|March 25, 2009
3D particle trajectories observed by orthogonal tracking microscopyMatthew D McMahon, Andrew J Berglund, Peter Carmichael, et al.
Hepatology Communications|February 16, 2019
An Inhibitor of Arginine-Glycine-Aspartate-Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic SteatohepatitisBarbara Ulmasov, Hidenao Noritake, Peter Carmichael, et al.
Experimental Gerontology|September 1, 2020
Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespanMi-Jung Kim, Chul Han, Karessa White, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|October 9, 2003
Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginineNathan W Luedtke, Peter Carmichael, Yitzhak Tor
ACS Nano|March 25, 2009
3D particle trajectories observed by orthogonal tracking microscopyMatthew D McMahon, Andrew J Berglund, Peter Carmichael, et al.
Hepatology Communications|February 16, 2019
An Inhibitor of Arginine-Glycine-Aspartate-Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic SteatohepatitisBarbara Ulmasov, Hidenao Noritake, Peter Carmichael, et al.
Experimental Gerontology|September 1, 2020
Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespanMi-Jung Kim, Chul Han, Karessa White, et al.
Pageof 1